Retatrutide ("Reta") in 2026: The Strongest Weight Loss Peptide Yet, and How to Get It From RxPepsDirect

Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP, FNP-BC. Last reviewed July 9, 2026.

The short answer

Retatrutide is the strongest weight loss peptide developed so far, and RxPepsDirect is bringing it. In its Phase 2 obesity trial, retatrutide produced 24.2 percent average weight loss over 48 weeks. Phase 3 has come in higher still, around 28 percent. Nothing else in the category, semaglutide or tirzepatide included, has matched those numbers.

There are two ways to get it, and the difference matters. Eli Lilly's branded version is still working through FDA trials and is not expected to reach the market until 2027 or 2028. Compounded retatrutide, prepared by a licensed 503A pharmacy under a prescription, does not wait for that. It is the early-access route, the same pathway that put compounded semaglutide and tirzepatide in patients' hands, and it is the one RxPepsDirect is preparing right now.

Our licensed pharmacy partner is in the final validation stage for a compounded retatrutide formulation. When it goes live, it will be prescribed by a licensed RxPepsDirect provider, tested for sterility and endotoxins, and shipped pre-reconstituted and ready to use. The fastest way to get it is to be on the list before it opens.

Prefer to start seeing results now? You can begin on tirzepatide today, and switch to retatrutide the day it goes live, with the same provider already on file.

Why retatrutide is the strongest one yet

Retatrutide is a triple-hormone-receptor agonist. It activates three metabolic receptors at once, where semaglutide activates one and tirzepatide activates two. That third receptor is the reason the trial numbers are so high, and the reason retatrutide is a genuinely new class rather than a stronger copy of what already exists.

Receptor 1: GLP-1 (appetite)

GLP-1 (glucagon-like peptide-1) is the gut hormone that tells your brain you are full, slows gastric emptying, and improves insulin response after eating. This is the core appetite-suppression pathway that made semaglutide and tirzepatide effective. Retatrutide keeps it.

Receptor 2: GIP (insulin sensitivity)

GIP (glucose-dependent insulinotropic polypeptide) is the second incretin hormone. Adding GIP agonism is what took tirzepatide beyond semaglutide: it improves insulin sensitivity and appears to buffer some of the nausea from GLP-1 activation. Retatrutide keeps this too.

Receptor 3: glucagon (the metabolic accelerator)

The third receptor is what sets retatrutide apart. Glucagon is usually thought of as the hormone that raises blood sugar, but glucagon receptor agonism also increases energy expenditure (your body burns more fuel at rest) and drives fat out of the liver. So where GLP-1 and GIP reduce how much you eat, the glucagon arm increases how much you burn and directly targets stored fat. An appetite brake and a metabolic accelerator in one weekly injection is why retatrutide reached weight loss figures that single and dual agonists have not. For the wider class, see the peptides for weight loss buyer's guide.

The trial data behind the hype

Retatrutide's Phase 2 obesity trial was published in the New England Journal of Medicine in 2023. Over 48 weeks, the 12mg dose produced 24.2 percent average weight loss, compared to 2.1 percent for placebo. For scale, that is in the range of bariatric surgery, from a weekly injection.

The Phase 3 program, called TRIUMPH, has reported even higher figures in its larger, longer studies: average weight loss around 28 percent. Those results are the reason retatrutide is the most anticipated weight loss drug in years.

That branded timeline is exactly why compounded retatrutide matters now. Waiting two or three years for Eli Lilly is not the only option. A licensed 503A pharmacy can compound the same molecule under a prescription today, which is how patients reach emerging therapies ahead of a branded launch, and it is the route RxPepsDirect is preparing.

Retatrutide vs tirzepatide vs semaglutide

Think of retatrutide as the next rung on a ladder you can already start climbing. Here is how the three compare, including how you get each one.

The two options you can start today are covered in depth in the semaglutide vs tirzepatide comparison and the compounded tirzepatide vs Mounjaro vs Zepbound guide, including pricing and dosing.

How you get retatrutide before the branded launch

Compounded medication is how patients access a molecule ahead of, or instead of, its branded version. A 503A compounding pharmacy prepares the medication to order under a prescription written by a licensed provider. This is the same pathway that made compounded semaglutide and tirzepatide widely available, and it is how retatrutide will reach RxPepsDirect patients while Eli Lilly's branded product is still years out.

What that looks like at RxPepsDirect: a licensed provider reviews your intake and writes the prescription, Optimal Balance Pharmacy compounds and fills it, every vial is tested for sterility and endotoxins, and it ships pre-reconstituted so there is no mixing on your end. Retatrutide is newer than the GLP-1s that came before it, so a provider decides whether it is right for you and sets your titration. That is the responsible version of early access, and it is the one we are building.

Not all compounded reta is the same

Search "reta peptides" and you will find research-chemical sites selling raw retatrutide powder with no provider, no prescription, and no way to verify what is in the vial. That is not the same product as a licensed-pharmacy compound, and it is worth being clear about the difference before you buy anything labeled "reta."

• Research-chemical "reta": anonymous seller, no prescriber, no medical screening, sold as "not for human use," and you reconstitute an unverified powder yourself.
• RxPepsDirect compounded retatrutide: a licensed provider prescribes it after screening you, a licensed 503A pharmacy compounds it, every batch is tested for sterility and endotoxins, and it ships pre-reconstituted and ready to use.

If you are comparing sources, the compounded peptides vs research peptides guide walks through exactly what separates a real pharmacy from a powder vendor.

Side effects and who it is not for

In the trials, retatrutide's side effects looked like the GLP-1 class it belongs to: nausea, diarrhea, vomiting, and constipation, worst during dose escalation and easing as the body adapts. A transient rise in heart rate was also seen. Slow titration, the same strategy used with semaglutide and tirzepatide, keeps the GI effects manageable, and your provider sets that schedule.

Because it works through the same incretin pathways, the class contraindications apply. Retatrutide is not appropriate for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, and it is not used in pregnancy or breastfeeding. A licensed RxPepsDirect provider screens for these before writing any prescription. That screening is part of what makes the licensed-pharmacy route the right one.

How to get retatrutide from RxPepsDirect

Retatrutide will follow the same simple model as every other RxPepsDirect medication: a one-time $39 provider review, a prescription written by a licensed provider (currently in 28 states), and fulfillment by Optimal Balance Pharmacy at wholesale, with the medication shipped pre-reconstituted. Final pricing is posted at launch.

Here is the fastest path to getting it:

• Join the waitlist. Add your email and mobile number to the form below and we will text you the day compounded retatrutide goes live. Waitlist patients get access first.
• Start on tirzepatide while you wait. It shares two of retatrutide's three mechanisms, delivers 15 to 22 percent in trials, and you can begin today at the weight loss peptide selection. Switching later is simple because your provider already has your file.
• Buy from a licensed source. When you are ready for retatrutide, get it from a provider and a licensed pharmacy, not an anonymous powder vendor.

Retatrutide is the biggest step forward in weight loss medicine in years, and it is almost here. Get on the list, make progress on a proven option in the meantime, and be one of the first to move up when reta goes live at RxPepsDirect.